波士顿科学Boston Scientific Corporation (BSX) 2013年年度报告「NYSE」.pdf

《波士顿科学Boston Scientific Corporation (BSX) 2013年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《波士顿科学Boston Scientific Corporation (BSX) 2013年年度报告「NYSE」.pdf（164页珍藏版）》请在三个皮匠报告上搜索。

1、Transforming Lives.2013 Annual Report44699.indd 344699.indd 33/15/14 11:11 AM3/15/14 11:11 AM35patients each minute52,000each day365,000each week19,000,000each yearTransforming LivesBoston Scientifi c is dedicated to transforming lives through innovative medical solutions that improve the health of

2、patients around the world.Boston Scientifi c Products Treat1:Pictured above and on the cover are Laura and her family.Like so many other patients,her life has been transformed by a Boston Scientifi c product.Throughout this Annual Report,unless otherwise noted,all revenue and growth rates represent

3、2013 growth compared to 2012 and all market sizes and Company market shares are Company estimates as of December 31,2013.Information on or connected to our website(or the website of any third party)referenced in this Annual Report is in addition to and not a part of or incorporated by reference into

4、 this Annual Report.1 Numbers are rounded averages based on Company sales and estimated usage patterns as of December 31,2013.44699.indd 444699.indd 43/17/14 10:13 AM3/17/14 10:13 AM2013 Sales by Product Category(Dollars in millions)2013%Rhythm ManagementCardiac Rhythm Management$1,88627%Electrophys

5、iology1552%CardiovascularInterventional Cardiology1,99728%Peripheral Interventions78911%MedSurgNeuromodulation4536%Endoscopy1,30018%Urology&Women s Health5057%7,08599%Divested Businesses2581%$7,143100%2013 Sales by Geographic Segment(Dollars in millions)2013%U.S.$3,74352%Japan74410%Other Countries2,

6、59837%7,08599%Divested Businesses2581%$7,143100%12100 countriesmanufacturing facilities worldwideMarket presence in$861Minvested in R&D$7.143Bin revenue Repurchased$500M in stock2 Sales from divested businesses include those generated from the Companys former Neurovascular business,sold to Stryker C